＜＜BACK

NEXT＞＞

Vol. 52 Suppl. 1 2024

SYMPOSIUM：The 15th Academic Meetings

Understanding Global Trends in Clinical Trials

K. Nakamura

Jpn Pharmacol Ther 2024; 52(s1): s7-9.

---

First-Ever Session by Students at a JSCTR Conference
"Students and Professionals Learning Together to Develop Human Resources in the Clinical Trial Industry"

N. Hida

Jpn Pharmacol Ther 2024; 52(s1): s10-12.

---

Considerations on Consent in Clinical Trials for Hyperacute Stroke Treatment:
Symposium Proceedings

M. Fukuda-Doi

Jpn Pharmacol Ther 2024; 52(s1): s13-15.

---

Improving the Efficiency of Case Data Collection in Clinical Trials
──Utilizing Direct Data Capture Based on Standardization of Electronic Medical Record Data

S. Hibino & Y. Matsumura

Jpn Pharmacol Ther 2024; 52(s1): s16-18.

---

Considering Post-Marketing Surveillance

M. Yoshioka

Jpn Pharmacol Ther 2024; 52(s1): s19-21.

---

Discussion about Endpoints in Clinical Trials in Patients with Palmoplantar Pustulosis

H. Koike et al.

Jpn Pharmacol Ther 2024; 52(s1): s22-25.

---

Challenges and Efforts to Ensure Data Flow and Reliability in Decentralized Clinical Trials （DCT）

Y. Tamura

Jpn Pharmacol Ther 2024; 52(s1): s26-28.

---

Development of Pharmaceuticals and Medical Devices
Using Real-World Data （RWD）

H. Hagiwara et al.

Jpn Pharmacol Ther 2024; 52(s1): s29-31.

---

Lead Diversifying Global Pharmaceutical Development
──Think Together About What We Can Do Now!

S. Suzuki & T. Okudaira

Jpn Pharmacol Ther 2024; 52(s1): s32-34.

---

Consider Medical Research and Regulations Act on the Protection
of Personal Information and Ethical Guidelines for Medical and
Biological Research Involving Human Subjects

K. Koide & Y. Tamura

Jpn Pharmacol Ther 2024; 52(s1): s35-38.

■ REVIEW ARTICLE

Patient-reported Outcome as Real World Data:
a Perspective from Data Utilization

T. Miyaji et al.

Jpn Pharmacol Ther 2024; 52(s1): s39-45.